Interference of silica nanoparticles with the traditional Limulus amebocyte lysate gel clot assay

Innate Immunity

Volumn 20, Issue 3, 2014, Pages 327-336

  Kucki, Melanie ^a   Cavelius, Christian ^a   Kraegeloh, Annette ^a  

^a INM LEIBNIZ INSTITUTE FOR NEW MATERIALS   (Germany)

Author keywords

Coagulation; endotoxin; horseshoe crab; lipopolysaccharide; nanomaterials

Indexed keywords

ENDOTOXIN; IRON OXIDE; NANOMATERIAL; NANOPARTICLE; SILICATE; SILICON DIOXIDE; FERRIC ION; FERRIC OXIDE; MACROGOL DERIVATIVE; METAL NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DILUTION; GEL; LIMULUS; LIMULUS LYSATE TEST; NONHUMAN; PROTEIN INTERACTION; PROTEIN PARTICLE INTERACTION; SURFACE PROPERTY; SUSPENSION; ANIMAL; CHEMISTRY; ELECTROCHEMISTRY; PARTICLE SIZE; PROCEDURES; STANDARD;

ANIMALS; ELECTROCHEMISTRY; ENDOTOXINS; FERRIC COMPOUNDS; LIMULUS TEST; METAL NANOPARTICLES; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; REFERENCE STANDARDS; SILICON DIOXIDE;

EID: 84899003658     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913492833     Document Type: Article

References (54)

1. Krug HF, Wick P. Nanotoxicology: an interdisciplinary challenge. Angew Chem Int Ed Engl. 2011 ; 50: 1260-1278
2. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007 ; 2: 469-478
3. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. MolPharm. 2008 ; 5: 487-495
4. Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia MA. Minireview: nanoparticles and the immune system. Endocrinology. 2009 ; 151: 458-465
5. Ragab AA, Van De Motter R, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res. 1999 ; 17: 803-809
6. Cho DR, Shanbhag AS, Hong C-Y, Baran GR, Goldring SR. The role of adsorbed endotoxin in particle-induced stimulation of cytokine release. J Orthop Res. 2002 ; 20: 705-713
7. Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, Scheynius A, et al. The Importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett. 2006 ; 6: 1682-1686
8. Shi Y, Yadav S, Wang F, Wang H. Endotoxin promotes adverse effects of amorphous silica nanoparticles on lung epithelial cells in vitro. J Toxicol Environ Health A. 2010 ; 73: 748-756
9. Smulders S, Kaiser J-P, Zuin S, Van Landuyt KL, Golanski L, Vanoirbeek J, et al. Contamination of nanoparticles by endotoxin: evaluation of different test methods. Part Fibre Toxicol. 2012 ; 9: 41-41
10. Muta T, Iwanaga S. The role of hemolymph coagulation in innate immunity. Curr Opin Immunol. 1996 ; 8: 41-47
11. Solum NO. The coagulation of Limulus polyphemus hemocytes - A comparison of the clotted and non-clotted forms of the molecule. Thromb Res. 1973 ; 2: 55-70
12. Kawabata Si, Muta T. Sadaaki Iwanaga: discovery of the lipopolysaccharide- and -1,3-D-glucan-mediated proteolytic cascade and unique proteins in invertebrate immunity. J Biochem. 2010 ; 147: 611-618
13. Novitsky TJ. Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. Innate Immun. 1994 ; 1: 253-263
14. Wörle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006 ; 6: 1261-1268
15. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol. 2009 ; 234: 222-235
16. Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, et al. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol. 2011 ; 8: 8-8
17. Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol. 2009 ; 4: 411-414
18. Dobrovolskaia MA, Neun B, Clogston JD, Ding H, Ljubimova J, McNeil SE. Ambiguities in applying traditional Limulus Amebocyte Lysate tests to quantify endotoxin in nanoparticle formulations. Nanomedicine. 2010 ; 5: 555-562
19. Schulze C, Kroll A, Lehr C-M, Schäfer UF, Becker K, Schnekenburger J, et al. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology. 2008 ; 2: 51-61
20. Dawson ME. Interference with the LAL test and how to address it. LAL update, Associates of Cape Cod, Inc., Woods Hole, MA, USA.. :
21. Fields M. Testing blood samples for endotoxin. LAL update, Associates of Cape Cod, Inc., Woods Hole, MA, USA, http://www.acciusa.com/pdfs/newsletter/ LALUpdateVol23-No2.pdf (2006, accessed 17 September 2012).
22. European Pharmacopoeia. European pharmacopoeia 5.0, 2.6.14. Bacterial endotoxins. France: EDQM Council of Europe, 2005. http://www.edqm.eu/en/ european-pharmacopoeia-7th-edition-1401.html.
23. Stoeber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J Coll Int Sci. 1968 ; 26: 62-69
24. Hartlen KD, Athanasopoulos APT, Kitaev V. Facile Preparation of highly monodisperse small silica spheres (15 to >200 nm) suitable for colloidal templating and formation of ordered arrays. Langmuir. 2008 ; 24: 1714-1720
25. Kucki M. Detection and semi-quantification of endotoxin contaminations in nanoparticle suspensions - Limulus amebocyte lysate (LAL) gel clot assay. DaNa project, http://www.nanopartikel.info/files/content/dana/Dokumente/Projekte/ SOPs/NanokonSOP222-geschützt.pdf (2012, accessed 3 August 2012).
26. ISO 29701:2010. Nanotechnologies - Endotoxin test on nanomaterial samples for in vitro systems - Limulus amebocyte lysate (LAL) test.
27. Dobrovolskaia MA and Neun B. NCL-Method-STE-1.3, detection and quantification of Gram negative bacterial endotoxin contamination in nanoparticle formulations by gel-clot LAL assay. Nanotechnology Characterization Laboratory, National Cancer Institute-Frederick, MD, USA, http://ncl.cancer. gov/NCL-Method-STE-1.3.pdf (2011, accessed 6 January 2012).
28. Neun BW, Dobrovolskaia MA Characterization of nanoparticles intended for drug delivery, methods in molecular biology. McNeil SE, ed. Series Volume 697, Springer Protocols. New York: Humana Press ; 2011: 121-130.
29. Darkow R, Groth T, Albrecht W, Lützow K, Paul D. Functionalized nanoparticles for endotoxin binding in aqueous solutions. Biomaterials. 1999 ; 20: 1277-1283
30. Bromberg L, Chang EP, Alvarez-Lorenzo C, Magariños B, Concheiro A, Hatton TA. Binding of functionalized paramagnetic nanoparticles to bacterial lipopolysaccharides and DNA. Langmuir. 2010 ; 26: 8829-8835
31. Piazza M, Colombo M, Zanoni I, Granucci F, Tortora P, Gioannini T, et al. Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling. Angew Chem. 2011 ; 123: 648-652
32. Gardiner KR, Anderson NH, McCaigue MD, Erwin PJ, Halliday MI, Rowlands BJ. Adsorbents as antiendotoxin agents in experimental colitis. Gut. 1993 ; 34: 51-55
33. Xing Z, Pabst MJ, Hasty KA, Smith RA. Accumulation of LPS by polyethylene particles decreases bone attachment to implants. J Orthop Res. 2006 ; 24: 959-966
34. Iwanaga S. The molecular basis of innate immunity in the horseshoe crab. Curr Opin Immunol. 2002 ; 14: 87-95
35. Ariki S. A serine protease zymogen functions as a pattern-recognition receptor for lipopolysaccharides. Proc Natl Acad Sci USA. 2004 ; 101: 953-958
36. Ariki S, Takahara S, Shibata T, Fukuoka T, Ozaki A, Endo Y, et al. Factor C acts as a lipopolysaccharide-responsive C3 convertase in horseshoe crab complement activation. J Immunol. 2008 ; 181: 7994-8001
37. Iwanaga S, Miyata T, Tokunaga F, Muta T. Molecular mechanism of hemolymph clotting system in Limulus. Thromb Res. 1992 ; 68: 1-32
38. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona:a comprehensive quantitative proteomic analysis. ACS Nano. 2011 ; 5: 7155-7167
39. Lozner EL, Taylor FHL. The effect of foreign surfaces on blood coagulation. J Clin Invest. 1942 ; 21: 241-245
40. Ratnoff OD, Rosenblum JM. Role of Hageman factor in the initiation of clotting by glass. Am J Med. 1958 ; 25: 160-168
41. Morrison DC, Cochrane CG. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med. 1974 ; 140: 797-811
42. Vogler EA and Graper JC. Partikel zur Verbesserung der Gerinnung in einem Blutentnahmeröhrchen durch Aktivieren zweier Reaktionswege, Blutentnahmeanordnung und Verfahren zur Herstellung der Partikel. DE patent EP 0 628 816 B1 DE 694 14 915 T2, Germany, 1994.
43. Tavano r, Segat D, Reddi E, Kos J, Rojnik M, Kocbek P, et al. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine. 2010 ; 5: 881-896
44. Maitz MF, Teichmann J, Sperling C, Werner C. Surface endotoxin contamination and hemocompatibility evaluation of materials. J Biomed Mater B Appl Biomater. 2008 ; 90B: 18-25
45. Patwardhan SV, Emami FS, Berry RJ, Jones SE, Naik RR, Deschaume O, et al. Chemistry of aqueous silica nanoparticle surfaces and the mechanism of selective peptide adsorption. J Am Chem Soc. 2012 ; 134: 6244-6256
46. Hansson KM, Tosatti S, Isaksson J, Wetterö J, Textor M, Lindahl TL, et al. Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces. Biomaterials. 2005 ; 26: 861-872
47. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. From the Cover: Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 2007 ; 104: 2050-2055
48. Solum NO, Mürer E. Early studies on the coagulogen (clotTable protein) of Limulus polyphemus (horseshoe crab). Thromb Haemost. 2007 ; 98: 129-130
49. Nakamura S, Takagi T, Iwanaga S, Niwa M, Takahashi K. Amino acid sequence studies on the fragments produced from horseshoe crab coagulogen during gel formation: homologies with primate fibrinopeptide B. Biochem Biophys Res Commun. 1976 ; 72: 902-908
50. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology. 2009 ; 20: 455101-455101
51. Kendall M, Ding P, Kendall K. Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology. Nanotoxicology. 2011 ; 5: 55-65
52. Roach P, Farrar D, Perry CC. Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J Am Chem Soc. 2006 ; 128: 3939-3945
53. Vroman L, Adams AL, Fischer GC, Munoz PC. Interaction of high molecular weight kininogen, factor xii, and fibrinogen in plasma at interfaces. Blood. 1980 ; 55: 156-159
54. Vroman L. The life of an artificial device in contact with blood: initial events and their effect on its final state. Bull NY Acad Med. 1988 ; 64: 352-357